Erratum: Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice (Journal of Clinical Investigation (2011) 121:2 (554-568) DOI: 10.1172/JCI43984);Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice

Journal of Clinical Investigation

Volumn 121, Issue 2, 2011, Pages 554-568

  Wüthrich, Marcel ^a   Gern, Benjamin ^a   Hung, Chiung Yu ^b   Ersland, Karen ^a   Rocco, Nicole ^a   Pick Jacobs, John ^a   Galles, Kevin ^a   Filutowicz, Hanna ^a   Warner, Thomas ^a   Evans, Michael ^a   Cole, Garry ^b   Klein, Bruce ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECTIN 1; FUNGUS VACCINE; MONOCLONAL ANTIBODY; MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLASTOMYCES DERMATITIDIS; CELL PROTECTION; COCCIDIOIDES POSADASII; COCCIDIOIDOMYCOSIS; ENDEMIC DISEASE; FUNGUS; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; IMMUNITY; LUNG INFECTION; MACROPHAGE; MOUSE; MYCOSIS; NEUTROPHIL; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; SYSTEMIC MYCOSIS; TH17 CELL;

EID: 79251491762     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI85788     Document Type: Erratum

References (79)

1. Pulendran B, Seder RA. Host-pathogen interactions in the 21st century. Curr Opin Immunol. 2005;17(4):335-337.
2. Cutler JE, Deepe GS Jr, Klein BS. Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol. 2007;5(1):13-28.
3. Mochon AB, Cutler JE. Is a vaccine needed against Candida albicans? Med Mycol. 2005;43(2):97-115.
4. Deepe GS Jr, Wuthrich M, Klein BS. Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol. 2005;43(5):381-389. (Pubitemid 41283040)
5. Cole GT, et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol. 2004;42(3):189-216.
6. Deepe GS Jr. Preventative and therapeutic vaccines for fungal infections: from concept to implementation. Expert Rev Vaccines. 2004;3(6):701-709.
7. Casadevall A, Pirofski LA. Feasibility and prospects for a vaccine to prevent cryptococcosis. Med Mycol. 2005;43(8):667-680.
8. Feldmesser M. Prospects of vaccines for invasive aspergillosis. Med Mycol. 2005;43(7):571-587.
9. Xue J, Chen X, Selby D, Hung CY, Yu JJ, Cole GT. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Infect Immun. 2009;77(8):3196-3208.
10. Wüthrich M, Filutowicz HI, Warner T, Deepe GS Jr, Klein BS. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med. 2003;197(11):1405-1416. (Pubitemid 36682540)
11. Wüthrich M, Filutowicz HI, Klein BS. Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance. J Clin Invest. 2000;106(11):1381-1389.
12. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36(1):1-53.
13. Allendorfer R, Brunner GD, Deepe GS Jr. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol. 1999;162(12):7389- 7396. (Pubitemid 29277716)
14. Wüthrich M, Filutowicz HI, Warner T, Klein BS. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol. 2002;169(12):6969-6976.
15. Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4(1):1-23.
16. Wüthrich M, Warner T, Klein BS. IL-12 is required for induction but not maintenance of protective, memory responses to blastomyces dermatitidis: implications for vaccine development in immunedeficient hosts. J Immunol. 2005;175(8):5288-5297.
17. Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. Clinical Microbiology Reviews. 1997;10(4):611-636.
18. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti- Candida albicans host defense in mice. J Infect Dis. 2004;190(3):624-631.
19. Conti HR, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009;206(2):299-311.
20. Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin- 23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun. 2007;75(6):3055-3061.
21. Deepe GS Jr, Gibbons RS. Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. J Infect Dis. 2009;200(1):142-151.
22. Werner JL, et al. Requisite role for the dectin- 1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol. 2009;182(8):4938-4946.
23. Zelante T, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol. 2007;37(10):2695-2706.
24. Rogers NC, et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity. 2005;22(4):507-517.
25. Underhill DM, Rossnagle E, Lowell CA, Simmons RM. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood. 2005;106(7):2543-2550.
26. Gross O, et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature. 2006;442(7103):651-656.
27. Goodridge HS, Simmons RM, Underhill DM. Dectin- 1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J Immunol. 2007;178(5):3107-3115.
28. LeibundGut-Landmann S, et al. Syk- and CARD9- dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007;8(6):630-638.
29. Taylor PR, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol. 2007;8(1):31-38.
30. Saijo S, et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol. 2007;8(1):39-46.
31. Kleinschek MA, et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol. 2006;176(2):1098-1106.
32. Forlow SB, Schurr JR, Kolls JK, Bagby GJ, Schwarzenberger PO, Ley K. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood. 2001;98(12):3309-3314.
33. Ye P, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001;194(4):519-527.
34. Tan W, Huang W, Zhong Q, Schwarzenberger P. IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation. J Immunol. 2006;176(10):6186-6193.
35. Liang SC, et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol. 2007;179(11):7791-7799.
36. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28(4):454-467.
37. Khader SA, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007;8(4):369-377.
38. Lin Y, et al. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity. 2009;31(5):799-810.
39. Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity. 2003;18(3):415-428. (Pubitemid 36351520)
40. Mullen AC, et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science. 2001;292(5523):1907-1910.
41. Nurieva R, Yang XO, Chung Y, Dong C. Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J Immunol. 2009;182(5):2565-2568.
42. Zimmermann CR, Johnson SM, Martens GW, White AG, Zimmer BL, Pappagianis D. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun. 1998;66(5):2342-2345. (Pubitemid 28194140)
43. Happel KI, et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med. 2005;202(6):761-769.
44. Higgins SC, Jarnicki AG, Lavelle EC, Mills KH. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol. 2006;177(11):7980-7989.
45. Osorio F, et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol. 2008;38(12):3274-3281.
46. Chung Y, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity. 2009;30(4):576-587.
47. Gutcher I, Urich E, Wolter K, Prinz M, Becher B. Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat Immunol. 2006;7(9):946-953.
48. LaRosa DF, et al. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc Natl Acad Sci U S A. 2008;105(10):3855-3860.
49. Lin L, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009;5(12):e1000703.
50. Acosta-Rodriguez EV, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8(6):639-646.
51. Milner JD, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper- IgE syndrome. Nature. 2008;452(7188):773-776.
52. Romani L, Kaufmann SH. Immunity to fungi: editorial overview [editorial]. Research in Immunology. 1998;149(4-5):277-281.
53. Fossiez F, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183(6):2593-2603.
54. Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene- alpha, and granulocyte-colony- stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol. 2002;26(6):748-753.
55. Kawaguchi M, et al. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol. 2001;108(5):804-809.
56. Laan M, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162(4):2347-2352. (Pubitemid 29288861)
57. Jaffar Z, Ferrini ME, Herritt LA, Roberts K. Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J Immunol. 2009;182(8):4507-4511.
58. Lubberts E, et al. Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J Immunol. 2005;175(5):3360-3368.
59. Leibundgut-Landmann S, Osorio F, Brown GD, Reis e Sousa C. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T cell responses. Blood. 2008;112(13):4971-4980.
60. Adachi O, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998;9(1):143-150.
61. Rivera A, et al. Innate immune activation and CD4(+) T cell priming during respiratory fungal infection. Immunity. 2006;25(4):665-675.
62. Fabien N, Bergerot I, Maguer-Satta V, Orgiazzi J, Thivolet C. Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice. Journal of Autoimmunity. 1995;8(3):323-334.
63. Mattner F, et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol. 1996;26(7):1553-1559.
64. Magram J, et al. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity. 1996;4(5):471-481. (Pubitemid 26354656)
65. Wu C, Wang X, Gadina M, O'Shea JJ, Presky DH, Magram J. IL-12 receptor beta 2 (IL-12R beta 2)- deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J Immunol. 2000;165(11):6221-6228.
66. Finotto S, et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 2002;295(5553):336-338.
67. Glaccum MB, et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol. 1997;159(7):3364-3371.
68. Hoshino K, et al. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol. 1999;162(9):5041-5044.
69. Nakae S, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002;17(3):375-387.
70. Thieu VT, et al. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity. 2008;29(5):679-690.
71. Harvey RP, Schmid ES, Carrington CC, Stevens DA. Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters. Am Rev Respir Dis. 1978;117(4):695-703.
72. Brandhorst TT, Wüthrich M, Warner T, Klein B. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med. 1999;189(8):1207-1216.
73. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med. 2009;206(1):43-49.
74. Chen CJ, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest. 2006;116(8):2262-2271.
75. Finkel-Jimenez B, Wüthrich M, Klein BS. BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms. J Immunol. 2002;168(11):5746-5755.
76. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008;83(1):64-70.
77. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte- differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol. 1993;151(5):2399-2408.
78. Fisher LD, van Belle G. The Bonferroni method (B method). Biostatistics: A Methodology for the Health Sciences. New York, New York, USA:John Wiley and Sons; 1993:611-613.
79. Wüthrich M, Filutowicz HI, Allen HL, Deepe GS, Klein BS. V{beta}1+ J{beta}1.1+/V{alpha}2+ J{alpha}49+ CD4+ T Cells Mediate Resistance against Infection with Blastomyces dermatitidis. Infect Immun. 2007;75(1):193-200.